Eli Lilly Chief AI Officer Thomas Fuchs on AI's Power to Transform Pharma
Inside the ICE House
•
21m
AI is revolutionizing pharmaceuticals, moving from a side tool to a core driver of many aspects of the industry. Eli Lilly is leading the way, appointing Thomas Fuchs as its first Chief AI Officer to integrate AI across its pipeline. A NASA and Mount Sinai veteran, Fuchs is turning Lilly’s data into a competitive edge. He joins Inside the ICE House to share how Lilly is building the AI-powered medicine company of the future.
Up Next in Inside the ICE House
-
Ellevest CEO & Co-Founder Sallie Kraw...
Sallie Krawcheck, CEO and Co-Founder of Ellevest, spent many years on Wall Street making “big calls on big stocks” as one of the top analysts in the industry, then climbed the ranks further through the highest echelons of financial services. She sits down Inside the ICE House to share her story o...
-
He's not the Oracle of Delphi, but he...
With the exception of Caesar's Palace, Las Vegas bears little resemblance to ancient Corinth, except that sometimes it beckons the great thinkers of the day. Against the backdrop of ICE Experience 2024, our gathering of the mortgage technology industry, former Treasury Secretary Larry Summers sat...
-
January Markets in Focus: GDP Strengt...
Phil Rosen joins Inside the ICE House to unpack why booming GDP is colliding with weaker job growth. He explains how AI-driven productivity lets companies boost earnings without expanding headcount. Rosen also discusses how boomer wealth and strong markets continue powering consumer spending. He ...
